Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (I/R) injury: Useful techniques for cardiovascular drug discovery

Ramesh Vidavalur, Snehasikta Swarnakar, Mahesh Thirunavukkarasu, Samson Mathews Samuel, Nilanjana Maulik

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better strategies or drug therapies to reduce ventricular remodeling and improve post-ischemic myocardial function. The ex-vivo isolated working heart model and the in vivo myocardial infarction model are the best known techniques to elucidate the contribution of a drug therapy to confer cardioprotection in the event of an ischemic insult/reperfusion. Our review aims to provide an insight into the state of the art techniques that lay the foundations for cardiovascular drug discovery and present the prospects for further development from a preclinical perspective. The first section of the review provides an overview of the rat/mouse ex-vivo and in vivo models of myocardial ischemia. The following section will then present various applications of these clinically relevant models in characterizing cardiac functions, screening for drugs and identifying the drug induced changes in cardiac functions. Finally the role of these models in drug development is discussed with respect to functional relevance of drug treatment on heart rate, aortic flow, coronary flow, infarct size and the mechanisms by which these drugs promote myocardial protection. This review may serve as a basic knowledge for researchers who intend to study the efficacy of a drug in the treatment of ischemic heart diseases.

Original languageEnglish
Pages (from-to)269-278
Number of pages10
JournalCurrent Drug Discovery Technologies
Volume5
Issue number4
DOIs
Publication statusPublished - 1 Dec 2008
Externally publishedYes

Fingerprint

Cardiovascular Agents
Drug Discovery
Reperfusion Injury
Myocardial Ischemia
Pharmaceutical Preparations
Drug Therapy
Preclinical Drug Evaluations
Ventricular Remodeling
Reperfusion
Myocardium
Therapeutics
Heart Rate
Myocardial Infarction
Research Personnel

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (I/R) injury : Useful techniques for cardiovascular drug discovery. / Vidavalur, Ramesh; Swarnakar, Snehasikta; Thirunavukkarasu, Mahesh; Mathews Samuel, Samson; Maulik, Nilanjana.

In: Current Drug Discovery Technologies, Vol. 5, No. 4, 01.12.2008, p. 269-278.

Research output: Contribution to journalReview article

@article{fda8d9646f394b4c8fd48ee6c499b033,
title = "Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (I/R) injury: Useful techniques for cardiovascular drug discovery",
abstract = "The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better strategies or drug therapies to reduce ventricular remodeling and improve post-ischemic myocardial function. The ex-vivo isolated working heart model and the in vivo myocardial infarction model are the best known techniques to elucidate the contribution of a drug therapy to confer cardioprotection in the event of an ischemic insult/reperfusion. Our review aims to provide an insight into the state of the art techniques that lay the foundations for cardiovascular drug discovery and present the prospects for further development from a preclinical perspective. The first section of the review provides an overview of the rat/mouse ex-vivo and in vivo models of myocardial ischemia. The following section will then present various applications of these clinically relevant models in characterizing cardiac functions, screening for drugs and identifying the drug induced changes in cardiac functions. Finally the role of these models in drug development is discussed with respect to functional relevance of drug treatment on heart rate, aortic flow, coronary flow, infarct size and the mechanisms by which these drugs promote myocardial protection. This review may serve as a basic knowledge for researchers who intend to study the efficacy of a drug in the treatment of ischemic heart diseases.",
author = "Ramesh Vidavalur and Snehasikta Swarnakar and Mahesh Thirunavukkarasu and {Mathews Samuel}, Samson and Nilanjana Maulik",
year = "2008",
month = "12",
day = "1",
doi = "10.2174/157016308786733555",
language = "English",
volume = "5",
pages = "269--278",
journal = "Current Drug Discovery Technologies",
issn = "1570-1638",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (I/R) injury

T2 - Useful techniques for cardiovascular drug discovery

AU - Vidavalur, Ramesh

AU - Swarnakar, Snehasikta

AU - Thirunavukkarasu, Mahesh

AU - Mathews Samuel, Samson

AU - Maulik, Nilanjana

PY - 2008/12/1

Y1 - 2008/12/1

N2 - The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better strategies or drug therapies to reduce ventricular remodeling and improve post-ischemic myocardial function. The ex-vivo isolated working heart model and the in vivo myocardial infarction model are the best known techniques to elucidate the contribution of a drug therapy to confer cardioprotection in the event of an ischemic insult/reperfusion. Our review aims to provide an insight into the state of the art techniques that lay the foundations for cardiovascular drug discovery and present the prospects for further development from a preclinical perspective. The first section of the review provides an overview of the rat/mouse ex-vivo and in vivo models of myocardial ischemia. The following section will then present various applications of these clinically relevant models in characterizing cardiac functions, screening for drugs and identifying the drug induced changes in cardiac functions. Finally the role of these models in drug development is discussed with respect to functional relevance of drug treatment on heart rate, aortic flow, coronary flow, infarct size and the mechanisms by which these drugs promote myocardial protection. This review may serve as a basic knowledge for researchers who intend to study the efficacy of a drug in the treatment of ischemic heart diseases.

AB - The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better strategies or drug therapies to reduce ventricular remodeling and improve post-ischemic myocardial function. The ex-vivo isolated working heart model and the in vivo myocardial infarction model are the best known techniques to elucidate the contribution of a drug therapy to confer cardioprotection in the event of an ischemic insult/reperfusion. Our review aims to provide an insight into the state of the art techniques that lay the foundations for cardiovascular drug discovery and present the prospects for further development from a preclinical perspective. The first section of the review provides an overview of the rat/mouse ex-vivo and in vivo models of myocardial ischemia. The following section will then present various applications of these clinically relevant models in characterizing cardiac functions, screening for drugs and identifying the drug induced changes in cardiac functions. Finally the role of these models in drug development is discussed with respect to functional relevance of drug treatment on heart rate, aortic flow, coronary flow, infarct size and the mechanisms by which these drugs promote myocardial protection. This review may serve as a basic knowledge for researchers who intend to study the efficacy of a drug in the treatment of ischemic heart diseases.

UR - http://www.scopus.com/inward/record.url?scp=57349157101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349157101&partnerID=8YFLogxK

U2 - 10.2174/157016308786733555

DO - 10.2174/157016308786733555

M3 - Review article

C2 - 19075607

AN - SCOPUS:57349157101

VL - 5

SP - 269

EP - 278

JO - Current Drug Discovery Technologies

JF - Current Drug Discovery Technologies

SN - 1570-1638

IS - 4

ER -